Stockscreener 앱 받기
1.89
1.06%
-0.03
전일 마감가:
$1.92
열려 있는:
$1.95
하루 거래량:
211.71K
Relative Volume:
0.18
시가총액:
$160.87M
수익:
-
순이익/손실:
$-59.69M
주가수익비율:
-1.3597
EPS:
-1.39
순현금흐름:
$-46.54M
1주 성능:
-0.54%
1개월 성능:
-9.97%
6개월 성능:
+45.02%
1년 성능:
+31.92%
1일 변동 폭
$1.89
$1.9574
1주일 범위
$1.76
$1.9574
52주 변동 폭
$0.6254
$2.75
Milestone Pharmaceuticals Inc Stock (MIST) Company Profile
명칭
Milestone Pharmaceuticals Inc
전화
(514) 336-0444
주소
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420, MONTREAL, QC
MIST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MIST
Milestone Pharmaceuticals Inc
|
1.8927 | 163.19M | 0 | -59.69M | -46.54M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.74 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.57 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.54 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
824.40 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.00 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Milestone Pharmaceuticals Inc Stock (MIST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-11 | 개시 | Wells Fargo | Overweight |
| 2025-06-05 | 재개 | H.C. Wainwright | Buy |
| 2024-08-22 | 개시 | Rodman & Renshaw | Buy |
| 2023-06-20 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-04-22 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-03-05 | 개시 | H.C. Wainwright | Buy |
| 2020-07-29 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-07-24 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-03-25 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-03-24 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-03-24 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-06-04 | 개시 | Oppenheimer | Outperform |
| 2019-06-03 | 개시 | Cowen | Outperform |
| 2019-06-03 | 개시 | Jefferies | Buy |
| 2019-06-03 | 개시 | Piper Jaffray | Overweight |
모두보기
Milestone Pharmaceuticals Inc 주식(MIST)의 최신 뉴스
Milestone Pharmaceuticals Reports Positive Efficacy and Safety Data for Etripamil Nasal Spray in Management of Paroxysmal Supraventricular Tachycardia - Quiver Quantitative
Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025 - Stock Titan
Is Milestone Pharmaceuticals Inc. stock bottoming outMarket Risk Summary & Community Consensus Picks - newser.com
Advanced analytics toolkit walkthrough for Milestone Pharmaceuticals Inc.July 2025 EndofMonth & Capital Protection Trading Alerts - newser.com
Will Milestone Pharmaceuticals Inc. stock remain a Wall Street favoriteJuly 2025 Sentiment & Verified Momentum Watchlists - newser.com
Combining price and volume data for Milestone Pharmaceuticals Inc.Trade Ideas & AI Enhanced Trading Signals - newser.com
Can Milestone Pharmaceuticals Inc. recover in the next quarterEarnings Recap Summary & Community Supported Trade Ideas - newser.com
Real time social sentiment graph for Milestone Pharmaceuticals Inc.Portfolio Performance Summary & Weekly Market Pulse Alerts - newser.com
How to interpret RSI for Milestone Pharmaceuticals Inc. stock2025 Macro Impact & Technical Confirmation Alerts - newser.com
What momentum shifts mean for Milestone Pharmaceuticals Inc.Weekly Trade Analysis & Reliable Entry Point Alerts - newser.com
What Fibonacci levels say about Milestone Pharmaceuticals Inc. reboundWeekly Gains Report & Low Risk Entry Point Tips - newser.com
How to forecast Milestone Pharmaceuticals Inc. trends using time seriesMarket Growth Review & Free Technical Pattern Based Buy Signals - newser.com
What the charts say about Milestone Pharmaceuticals Inc. today2025 Biggest Moves & Low Risk High Win Rate Picks - newser.com
How Milestone Pharmaceuticals Inc. stock performs during Fed tightening cycles2025 Stock Rankings & Free Verified High Yield Trade Plans - newser.com
Is it too late to sell Milestone Pharmaceuticals Inc.July 2025 Analyst Calls & Real-Time Volume Spike Alerts - newser.com
Can Milestone Pharmaceuticals Inc. stock maintain operating marginsPortfolio Value Summary & Daily Stock Trend Watchlist - newser.com
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Given Average Rating of "Hold" by Brokerages - MarketBeat
Detecting support and resistance levels for Milestone Pharmaceuticals Inc.Oil Prices & Fast Exit/Entry Strategy Plans - newser.com
Is Milestone Pharmaceuticals Inc a good long term investmentSwing Trading Watchlist & Build Wealth Brick by Brick With Us - earlytimes.in
Milestone Pharmaceuticals Inc (MIST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.03%
0.32%
자본화:
|
볼륨(24시간):